Placebo MDPI
Sponsors
Teva Branded Pharmaceutical Products R&D, Inc.
Conditions
Asthma
Phase 2
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids
CompletedNCT01479621
Start: 2012-01-31End: 2013-07-31Updated: 2017-06-05
A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications
CompletedNCT01576718
Start: 2012-04-30End: 2013-10-31Updated: 2018-05-08
Phase 3
A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma
CompletedNCT01424813
Start: 2012-12-31End: 2013-11-30Updated: 2015-06-26
Safety Study of Albuterol Spiromax® in Subjects With Asthma
CompletedNCT01698320
Start: 2012-10-31End: 2013-12-31Updated: 2015-08-19
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
CompletedNCT01747629
Start: 2012-12-31End: 2013-11-30Updated: 2015-06-26
Study of Fluticasone Propionate MDPI Compared With Fluticasone/Salmeterol MDPI in Adolescent and Adult Patients With Persistent Asthma
CompletedNCT02139644
Start: 2014-06-30End: 2015-09-30Updated: 2021-11-12
Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma
CompletedNCT02141854
Start: 2014-06-30End: 2015-09-30Updated: 2021-11-09
Study of Fluticasone Propionate Multidose Dry Powder Inhaler Compared With Fluticasone Propionate/Salmeterol Multidose Dry Powder Inhaler
CompletedNCT02980133
Start: 2016-12-28End: 2019-04-13Updated: 2021-11-09